| |
|
2010 |
2009 |
2008 |
2007 |
2006 |
 |
| |
|
|
|
|
|
|
| Net sales |
M€ |
716 |
660 |
697 |
647 |
530 |
| of which outside Finland |
M€ |
550 |
519 |
546 |
553 |
486 |
| in percent of net sales |
% |
76.8 |
78.6 |
78.2 |
85.4 |
91.8 |
| export from Finland |
M€ |
77 |
89 |
98 |
79 |
59 |
| Percentage change of net sales |
% |
8.4 |
-5.3 |
7.7 |
22.1 |
3.8 |
 |
| Gross profit |
M€ |
254 |
221 |
213 |
210 |
155 |
| in percent of net sales |
% |
35.4 |
33.5 |
5.6 |
12.3 |
9.7 |
| Operating profit (EBIT) |
M€ |
49 |
39 |
6 |
54 |
22 |
| in percent of net sales |
% |
6.9 |
6.0 |
0.9 |
8.3 |
4.2 |
 |
| Operating profit excluding non-recurring items |
M€ |
60 |
40 |
41 |
52 |
33 |
 |
| Share of profit from associates |
M€ |
66 |
66 |
70 |
43 |
59 |
| Change in fair value of biological assets |
M€ |
-2 |
0 |
-6 |
10 |
5 |
| Financial items net |
M€ |
-6 |
-14 |
-19 |
13 |
-9 |
| in percent of net sales |
% |
-0.9 |
-2.2 |
-2.8 |
2.0 |
-1.7 |
| Profit before taxes |
M€ |
107 |
91 |
52 |
120 |
77 |
| in percent of net sales |
% |
14.9 |
13.8 |
7.4 |
18.5 |
14.5 |
| Income tax (continuing operations) |
M€ |
-12 |
-8 |
-2 |
-11 |
-10 |
| Profit from discontinued operations |
M€ |
|
|
|
|
15 |
 |
| Profit for the period attributable to the equity holders of the company |
M€ |
94 |
84 |
49 |
108 |
82 |
| in percent of net sales |
% |
13.2 |
12.7 |
7.1 |
16.8 |
15.5 |
| Minority interest |
M€ |
0.0 |
0.0 |
-0.1 |
0.3 |
0.0 |
 |
| Employee benefits |
M€ |
173 |
165 |
187 |
146 |
121 |
| Depreciation and amortization |
M€ |
35 |
28 |
33 |
23 |
29 |
| in percent of net sales |
% |
4.9 |
4.3 |
4.7 |
3.6 |
5.4 |
| Cash flow from operating activities |
M€ |
93 |
121 |
97 |
82 |
99 |
| Capital expenditure (incl. acquisitions) |
M€ |
19 |
15 |
30 |
221 |
41 |
| in percent of net sales |
% |
2.6 |
2.2 |
4.3 |
34.1 |
7.7 |
| Research and development costs in income statement |
M€ |
8 |
9 |
8 |
7 |
6 |
| in percent of net sales |
% |
1.2 |
1.3 |
1.2 |
1.1 |
1.2 |
| Capitalized development costs |
M€ |
1 |
0 |
1 |
1 |
1 |
 |
| Equity attributable to equity holders of the company |
M€ |
553 |
505 |
447 |
478 |
422 |
| Minority interest |
M€ |
0.0 |
0.0 |
0.0 |
0.5 |
0.0 |
| Equity total |
M€ |
553 |
505 |
447 |
478 |
422 |
| Net interest bearing debt |
M€ |
200 |
236 |
310 |
319 |
102 |
| Working capital |
M€ |
101 |
103 |
149 |
162 |
104 |
| Balance sheet total |
M€ |
979 |
973 |
970 |
1,047 |
707 |
 |
| Return on investment |
% |
15 |
14 |
9 |
19 |
18 |
| Return on equity |
% |
18 |
18 |
11 |
25 |
20 |
| Equity ratio |
% |
57 |
52 |
46 |
46 |
60 |
| Net gearing |
% |
36 |
47 |
69 |
67 |
24 |
 |
| Personnel (FTE), average |
|
3,612 |
3,867 |
4,325 |
3,517 |
3,167 |
| Personnel, end of period |
|
3,944 |
3,742 |
4,119 |
4,515 |
3,003 |
| of which outside Finland |
|
2,373 |
2,111 |
2,397 |
2,662 |
2,224 |
 |
Discontinued operations include Power Sentry in 2006.